Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer is a research paper published in Theranostics (2020). On theSindex it has a DataRank of 0. It has been cited 38 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: U01 CA183031
NCI NIH HHS
Grant: R01 CA116477
NCI NIH HHS
Grant: R01 CA134675
NCI NIH HHS
Grant: R01 CA184228
NIBIB NIH HHS
Grant: R21 EB005324
NCI NIH HHS
Grant: R01 CA157542
National Institutes of Health
Grant: 2R01CA184228-06
Small Molecule PSMA-Targeted Alpha Therapy
National Institutes of Health
Grant: 5U01CA183031-02
PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics
National Institutes of Health
Grant: 1R01CA157542-01A1
Modeling Targeted Alpha Particle Therapy of Cancer
National Institutes of Health
Grant: 5R01CA134675-03
PSMA-based Cancer Imaging Agents
National Institutes of Health
Grant: 5R01CA116477-08
Dose-Response in Radionuclide Therapy
FWCI
3.07
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals